Your browser doesn't support javascript.
loading
Multiomics interrogation into HBV (Hepatitis B virus)-host interaction reveals novel coding potential in human genome, and identifies canonical and non-canonical proteins as host restriction factors against HBV.
Yuan, Shilin; Liao, Guanghong; Zhang, Menghuan; Zhu, Yuanfei; Xiao, Weidi; Wang, Kun; Li, Chuanyin; Jia, Caiwei; Sun, Na; Walch, Axel; Gao, Daming; Xu, Ping; Deng, Qiang; Zhang, Jian; Wang, He; Hu, Ronggui.
Afiliación
  • Yuan S; Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Liao G; State Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.
  • Zhang M; University of Chinese Academy of Sciences, Beijing, China.
  • Zhu Y; State Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.
  • Xiao W; University of Chinese Academy of Sciences, Beijing, China.
  • Wang K; State Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.
  • Li C; Key Laboratory of Medical Molecular Virology (MOE & MOH), School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Jia C; State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Research Unit of Proteomics & Research and Development of New Drug of Chinese Academy of Medical Sciences, Beijing Institute of Lifeomics, Beijing, China.
  • Sun N; Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Walch A; Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Gao D; Cancer Center, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Xu P; Research Unit Analytical Pathology, Helmholtz Zentrum München, Neuherberg, Germany.
  • Deng Q; Research Unit Analytical Pathology, Helmholtz Zentrum München, Neuherberg, Germany.
  • Zhang J; State Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.
  • Wang H; State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Research Unit of Proteomics & Research and Development of New Drug of Chinese Academy of Medical Sciences, Beijing Institute of Lifeomics, Beijing, China. xuping_bprc@126.com.
  • Hu R; Key Laboratory of Medical Molecular Virology (MOE & MOH), School of Basic Medical Sciences, Fudan University, Shanghai, China. qdeng@fudan.edu.cn.
Cell Discov ; 7(1): 105, 2021 Nov 02.
Article en En | MEDLINE | ID: mdl-34725333

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cell Discov Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cell Discov Año: 2021 Tipo del documento: Article País de afiliación: China